Showing results (231-240 of 395) with videos related to

Sort By:
Pageof 40
Breast Cancer Research : BCR|January 1, 2020
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrenceFabio Conforti, Laura Pala, Eleonora Pagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VIIA Wallgren, M Bonetti, R D Gelber, et al.
Clinical Breast Cancer|January 12, 2020
Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast CancerJosé Bines, Marion Procter, Eleonora Restuccia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 studyClive S Grant, James N Ingle, Vera J Suman, et al.
The New England Journal of Medicine|December 31, 2005
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, Beat Thürlimann, Aparna Keshaviah, et al.
Breast Cancer Research and Treatment|April 28, 2025
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trialChristian Maurer, Elisa Agostinetto, Lieveke Ameye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, Carl-Magnus Rudenstam, David Zahrieh, et al.
Breast Cancer Research and Treatment|September 20, 2020
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D)Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2007
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trialHenning Mouridsen, Aparna Keshaviah, Alan S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2008
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 TrialB C Pestalozzi, P Francis, E Quinaux, et al.
Pageof 40